Smartphones, artificial intelligence and digital histopathology take on basal cell carcinoma diagnosis by Lee, K. J. & Soyer, H. P.
This is the author manuscript accepted for publication and has undergone full peer review but 
has not been through the copyediting, typesetting, pagination and proofreading process, which 
may lead to differences between this version and the Version of Record. Please cite this article 
as doi: 10.1111/BJD.18374
This article is protected by copyright. All rights reserved
DRO 22.7.19
Commentary 19/1327
Smartphones, artificial intelligence and digital histopathology take on basal cell 
carcinoma diagnosis
Linked Article: Jiang et al. Br J Dermatol 2019; [19/255]
In this issue of the BJD, Jiang and colleagues report a method of using smartphone images to 
submit histology slides of suspected basal cell carcinomas (BCCs) to analysis and diagnosis 
with a deep neural network.1 The smartphone microscope ocular images (MOIs), taken 
through the eyepiece of a microscope at 10 × magnification attached to a smartphone, 
performed as well as the more traditional, but much larger, whole-slide images (WSIs). The 
authors also found that computational resource needs could be reduced by separating 
straightforward from difficult cases and applying a more intensive analysis to the difficult 
cases only.
BCC is the most common cancer in humans worldwide,2 and the sheer number of cases 
makes histopathological diagnosis time consuming, although generally straightforward. 
Information-rich histopathology slides are an ideal subject for computer-assisted diagnosis, 
and researchers are already investigating artificial intelligence histopathological analysis of a 
variety of cancers, including breast, cervical, prostate, pancreatic and lung cancer.3 This study 
shows that even less-than-ideal histopathology slides, such as poorly focused 
photomicrographs taken with a smartphone, can be analysed with artificial intelligence. 
One drawback to digital histopathology is that, while it is has equivalent accuracy, it is 
slower to perform than traditional reading from glass slides and requires excellent bandwidth 
and network connectivity to enable efficient loading of data-heavy images.4 The size of the 
images required in this study was greatly reduced by using smartphone-captured MOI images 
instead of WSI. Although WSI systems can save slide images at up to 400 × magnification, 
the MOI needs only 10 × magnification, as BCC diagnosis relies more on overall 
architectural features rather than cellular structures. These smaller file sizes may assist where 
the network used has limited bandwidth or storage capacity.
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A barrier to the use of artificial intelligence in medicine can be the high computational 
resources required to process detail-heavy images, which may leave low- and middle-income 
countries unable to benefit from this technology. Jiang and colleagues have approached this 
issue by incorporating a means of distinguishing difficult cases from more straightforward 
cases into an early step of the algorithm. Their convolutional neural network predicts whether 
the image contains a BCC or not, and assigns a confidence level. Images with a low 
confidence level (‘difficult’ cases) are then submitted to a more computationally intensive 
pixelwise segmentation. Compared with submitting all cases to pixelwise segmentation, the 
‘cascade’ framework, which reserves the more detailed analysis for hard cases only, is almost 
75% faster, without much reduction in accuracy. 
As with many forays into artificial intelligence, this paper has concentrated on a binary 
BCC/not BCC classification. Although this is a valuable first step, future work will need to 
combine BCC diagnosis with a range of other diagnoses, not least the other major skin 
cancers, squamous cell carcinoma and melanoma. 
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